FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387018573> ?p ?o ?g. }

• W4387018573 abstract "The PI3K-Akt-mTOR (PAM) pathway is implicated in tumor progression in many tumor types, including metastatic gastric cancer (GC). The initial promise of PAM inhibitors has been unrealized in the clinic, presumably due, in part, to the up-regulation of Akt signaling that occurs when the pathway is inhibited. Here we present that DIACC3010 (formerly M2698), an inhibitor of two nodes in the PAM pathway, p70S6K and Akt 1/3, blocks the pathway in in vitro and in vivo preclinical models of GC while providing a mechanism that inhibits signaling from subsequent Akt up-regulation. Utilizing GC cell lines and xenograft models, we identified potential markers of DIACC3010-sensitivity in Her2-negative tumors, i.e., PIK3CA mutations, low basal pERK, and a group of differentially expressed genes (DEGs). The combination of DIACC3010 and trastuzumab was evaluated in Her2-positive cell lines and models. Potential biomarkers for the synergistic efficacy of the combination of DIACC3010 + trastuzumab also included DEGs as well as a lack of up-regulation of pERK. Of 27 GC patient-derived xenograft (PDX) models tested in BALB/c nu/nu mice, 59% were sensitive to DIACC3010 + trastuzumab. Of the 21 HER2-negative PDX models, DIACC3010 significantly inhibited the growth of 38%. Altogether, these results provide a path forward to validate the potential biomarkers of DIACC3010 sensitivity in GC and support clinical evaluation of DIACC3010 monotherapy and combination with trastuzumab in patients with HER2- negative and positive advanced GCs, respectively." @default.
• W4387018573 created "2023-09-26" @default.
• W4387018573 creator A5001115937 @default.
• W4387018573 creator A5001768545 @default.
• W4387018573 creator A5006128388 @default.
• W4387018573 creator A5006401578 @default.
• W4387018573 creator A5008483863 @default.
• W4387018573 creator A5015799240 @default.
• W4387018573 creator A5033030596 @default.
• W4387018573 creator A5044127975 @default.
• W4387018573 creator A5046904598 @default.
• W4387018573 creator A5051774299 @default.
• W4387018573 creator A5062748030 @default.
• W4387018573 creator A5065197387 @default.
• W4387018573 creator A5068779813 @default.
• W4387018573 creator A5069779817 @default.
• W4387018573 creator A5078243255 @default.
• W4387018573 creator A5082685387 @default.
• W4387018573 date "2023-09-25" @default.
• W4387018573 modified "2023-10-17" @default.
• W4387018573 title "p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab" @default.
• W4387018573 cites W1556314914 @default.
• W4387018573 cites W1600230194 @default.
• W4387018573 cites W1964296201 @default.
• W4387018573 cites W1987009448 @default.
• W4387018573 cites W1995031206 @default.
• W4387018573 cites W1998203489 @default.
• W4387018573 cites W2025344915 @default.
• W4387018573 cites W2029420654 @default.
• W4387018573 cites W2039301709 @default.
• W4387018573 cites W2059755429 @default.
• W4387018573 cites W2060182728 @default.
• W4387018573 cites W2070594517 @default.
• W4387018573 cites W2073827381 @default.
• W4387018573 cites W2098584395 @default.
• W4387018573 cites W2100439220 @default.
• W4387018573 cites W2104239861 @default.
• W4387018573 cites W2115147179 @default.
• W4387018573 cites W2115175735 @default.
• W4387018573 cites W2118160355 @default.
• W4387018573 cites W2134392974 @default.
• W4387018573 cites W2136701318 @default.
• W4387018573 cites W2147551134 @default.
• W4387018573 cites W2150413138 @default.
• W4387018573 cites W2151834271 @default.
• W4387018573 cites W2169338340 @default.
• W4387018573 cites W2170567505 @default.
• W4387018573 cites W2268975203 @default.
• W4387018573 cites W2333973238 @default.
• W4387018573 cites W2399487210 @default.
• W4387018573 cites W2466335605 @default.
• W4387018573 cites W2481719227 @default.
• W4387018573 cites W2548756381 @default.
• W4387018573 cites W2582949459 @default.
• W4387018573 cites W2613226689 @default.
• W4387018573 cites W2617653110 @default.
• W4387018573 cites W2744377419 @default.
• W4387018573 cites W2763064222 @default.
• W4387018573 cites W2779896047 @default.
• W4387018573 cites W2799823145 @default.
• W4387018573 cites W2886987811 @default.
• W4387018573 cites W2889646458 @default.
• W4387018573 cites W2891879746 @default.
• W4387018573 cites W2905730463 @default.
• W4387018573 cites W2910775131 @default.
• W4387018573 cites W2945564879 @default.
• W4387018573 cites W2946261681 @default.
• W4387018573 cites W2947171117 @default.
• W4387018573 cites W2951331974 @default.
• W4387018573 cites W2958034733 @default.
• W4387018573 cites W2980338169 @default.
• W4387018573 cites W3009037180 @default.
• W4387018573 cites W3020446897 @default.
• W4387018573 cites W3026926990 @default.
• W4387018573 cites W3045134544 @default.
• W4387018573 cites W3084052359 @default.
• W4387018573 cites W3087152814 @default.
• W4387018573 cites W3202613568 @default.
• W4387018573 cites W3210815187 @default.
• W4387018573 cites W4288734447 @default.
• W4387018573 doi "https://doi.org/10.1038/s41598-023-40612-9" @default.
• W4387018573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37749105" @default.
• W4387018573 hasPublicationYear "2023" @default.
• W4387018573 type Work @default.
• W4387018573 citedByCount "0" @default.
• W4387018573 crossrefType "journal-article" @default.
• W4387018573 hasAuthorship W4387018573A5001115937 @default.
• W4387018573 hasAuthorship W4387018573A5001768545 @default.
• W4387018573 hasAuthorship W4387018573A5006128388 @default.
• W4387018573 hasAuthorship W4387018573A5006401578 @default.
• W4387018573 hasAuthorship W4387018573A5008483863 @default.
• W4387018573 hasAuthorship W4387018573A5015799240 @default.
• W4387018573 hasAuthorship W4387018573A5033030596 @default.
• W4387018573 hasAuthorship W4387018573A5044127975 @default.
• W4387018573 hasAuthorship W4387018573A5046904598 @default.
• W4387018573 hasAuthorship W4387018573A5051774299 @default.
• W4387018573 hasAuthorship W4387018573A5062748030 @default.
• W4387018573 hasAuthorship W4387018573A5065197387 @default.
• W4387018573 hasAuthorship W4387018573A5068779813 @default.
• W4387018573 hasAuthorship W4387018573A5069779817 @default.

• next